BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18317463)

  • 1. Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: interactions with gonadal steroids and stress.
    Zubenko GS; Hughes HB
    Mol Psychiatry; 2009 Apr; 14(4):390-7. PubMed ID: 18317463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the G(-656)A variant on CREB1 promoter activity in a glial cell line: interactions with gonadal steroids and stress.
    Zubenko GS; Hughes HB
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):579-85. PubMed ID: 18213625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the A(-115)G variant on CREB1 promoter activity in two brain cell lines: Interactions with gonadal steroids.
    Zubenko GS; Hughes HB
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1365-72. PubMed ID: 20957653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variations in CREB1 cosegregate with depressive disorders in women.
    Zubenko GS; Hughes HB; Stiffler JS; Brechbiel A; Zubenko WN; Maher BS; Marazita ML
    Mol Psychiatry; 2003 Jun; 8(6):611-8. PubMed ID: 12851637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.
    Zubenko GS; Hughes HB
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jul; 156B(5):517-31. PubMed ID: 21598377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of brain anatomy in mouse model of MDD created by replacement of homologous mouse DNA sequence with an illness-associated 6-base human CREB1 promoter sequence.
    Zubenko GS; Hughes HB; Hitchens TK; Cohen BM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):1-8. PubMed ID: 24006268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression.
    Zubenko GS; Hughes HB; Maher BS; Stiffler JS; Zubenko WN; Marazita ML
    Am J Med Genet; 2002 Dec; 114(8):980-7. PubMed ID: 12457397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic linkage of region containing the CREB1 gene to depressive disorders in families with recurrent, early-onset, major depression: a re-analysis and confirmation of sex-specific effect.
    Maher BS; Hughes HB; Zubenko WN; Zubenko GS
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):10-6. PubMed ID: 19517574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.
    Xiao X; Zhang C; Grigoroiu-Serbanescu M; Wang L; Li L; Zhou D; Yuan TF; Wang C; Chang H; Wu Y; Li Y; Wu DD; Yao YG; Li M
    Mol Psychiatry; 2018 Sep; 23(9):1957-1967. PubMed ID: 29158582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of non-homologous insertions in mouse model of MDD created by replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence.
    Zubenko GS; Hughes HB
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):1-4. PubMed ID: 22180334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression.
    Zubenko GS; Maher B; Hughes HB; Zubenko WN; Stiffler JS; Kaplan BB; Marazita ML
    Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):1-18. PubMed ID: 14582139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of CREB1 with Major Depressive Disorder and related phenotypes.
    Hettema JM; An SS; van den Oord EJ; Neale MC; Kendler KS; Chen X
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1128-32. PubMed ID: 19194961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD).
    Wang P; Yang Y; Yang X; Qiu X; Qiao Z; Wang L; Zhu X; Sui H; Ma J
    Int J Clin Exp Pathol; 2015; 8(1):906-13. PubMed ID: 25755794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
    Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
    Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder.
    Zubenko GS; Hughes HB; Jordan RM; Lyons-Weiler J; Cohen BM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Sep; 165B(6):457-66. PubMed ID: 25059218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway.
    Liu JL; Papachristou DN; Patel YC
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):863-9. PubMed ID: 7914402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
    Perlis RH; Purcell S; Fagerness J; Cusin C; Yamaki L; Fava M; Smoller JW
    Biol Psychiatry; 2007 Sep; 62(5):536-40. PubMed ID: 17300755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREB mediates the cAMP-responsiveness of the tyrosine hydroxylase gene: use of an antisense RNA strategy to produce CREB-deficient PC12 cell lines.
    Piech-Dumas KM; Tank AW
    Brain Res Mol Brain Res; 1999 Jul; 70(2):219-30. PubMed ID: 10407170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The species-specific differences in the cAMP regulation of the tissue-type plasminogen activator gene between rat, mouse and human is caused by a one-nucleotide substitution in the cAMP-responsive element of the promoters.
    Holmberg M; Leonardsson G; Ny T
    Eur J Biochem; 1995 Jul; 231(2):466-74. PubMed ID: 7543410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.